Medicare AdvantagePrior AuthHigh impact
Comprehensive Genomic Profiling and Multigene Panel Testing for Solid Tumors - Medicare Advantage (Revised)
Humana·Oncology, Pathology, Internal Medicine·Medicare Advantage
Effective date
Aug 3, 2026
We identified it
Jul 30, 2026
Summary
This is a revised Medicare Advantage policy (effective 08/03/2026) that updates coverage requirements for Comprehensive Genomic Profiling and Multigene Panel Testing for solid tumors. The policy establishes coverage criteria, coding guidelines, and references multiple MAC-specific Local Coverage Determinations (LCDs) across different geographic jurisdictions. Billing teams must align submissions with applicable MAC LCDs and ensure proper documentation of medical necessity for NGS testing in cancer patients.
Action Required
By August 3, 2026: Billing team must review and implement MAC-specific LCD requirements for CGP/multigene panel testing based on geographic jurisdiction. Action items: (1) Identify applicable MAC LCD for your service area using the provided MAC/state matrix (e.g., J15 for KY/OH, JE for CA/HI/NV, JH for AR/CO/NM/OK/TX/LA/MS); (2) Update billing system to enforce required prior authorization protocols per applicable MAC LCD (MolDX: Next-Generation Sequencing for Solid Tumors or equivalent); (3) Revise encounter templates and provider documentation requirements to capture medical necessity, tumor type, and indication for testing; (4) Train providers and front-desk staff on new documentation standards for solid tumor NGS testing; (5) Configure claims submission logic to route claims to correct MAC and include required modifiers per MolDX guidelines; (6) Cross-reference related pharmacy policies (Keytruda, Lynparza, Tagrisso, etc.) to ensure targeted therapy eligibility pre-authorization; (7) Implement claim scrubbing rules to deny or delay claims lacking proper documentation and prior authorization. Consequences: Claims submitted without MAC-compliant documentation and prior authorization will be denied; misrouted claims to incorrect MAC jurisdiction will experience processing delays.